FSHR and prostate cancer: The latter observations corroborate with the earlier findings of Ben-Josef et al. [5] who reported on the FSHR expression in androgen-independent prostate cancer cells PC3 and DU145 and that of Sardella et al. [6] who found the expression of FSHR in the tumoral cells of neuroendocrine pancreatic tumours.